Log In
Print
BCIQ
Print
Print this Print this
 

Concerta, methylphenidate

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionOnce-daily Oros controlled extended-release formulation of methylphenidate
Molecular Target Dopamine transporter
Mechanism of ActionDopamine and norepinephrine reuptake inhibitor
Latest Stage of DevelopmentMarketed
IndicationAttention deficit hyperactivity disorder (ADHD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today